Clinical Evaluation of New Generation Oxygenators With Integrated Arterial Line Filters for Cardiopulmonary Bypass

Artificial Organs

Volumn 36, Issue 10, 2012, Pages 875-885

  Onorati, Francesco ^a   Santini, Francesco ^a   Raffin, Federica ^a   Menon, Tiziano ^a   Graziani, Maria S ^a   Chiominto, Bartolomeo ^a   Milano, Aldo ^a   Faggian, Giuseppe ^a   Mazzucco, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Arterial filter; Cardiopulmonary bypass; Integrated arterial filters; Oxygenators

Indexed keywords

BANDPASS FILTERS; BIOSYNTHESIS; BLOOD VESSELS; BODY FLUIDS; DROPS; PORE SIZE; PROTEINS;

ARTERIAL FILTERS; C-REACTIVE PROTEINS; CARDIOPULMONARY BYPASS; CLINICAL OUTCOME; GAS EXCHANGE; HIGH SENSITIVITY; INTEGRATED ARTERIAL FILTER; INTERNATIONAL NORMALIZED RATIOS; LINE FILTERS;

PRESSURE DROP;

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN; FRESH FROZEN PLASMA;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL EVALUATION; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; FEMALE; FILTER; FLUID BALANCE; GAS EXCHANGE; HUMAN; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OXYGENATOR; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 84867208023     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01469.x     Document Type: Article

References (32)

1. Shann KG, Likosky DS, Murkin JM, etal. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006;132:283-90.
2. Murphy GS, Hessel EA, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009;108:1394-417.
3. Lorusso R, De Cicco G, Totaro P, Gelsomino S. Effects of phosphorylcoline coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study. Interact Cardiovasc Thorac Surg 2009;8:7-11.
4. Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg 2002;124:321-32.
5. Mahoney CB, Lemole GM. Transfusions after coronary artery bypass surgery: the impact of heparin-bonded circuits. Eur J Cardiothorac Surg 1999;16:206-10.
6. Mongero LB, Beck JR, Manspeizer EJ, etal. Cardiac surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than patients to non-heparin-bonded circuits. Perfusion 2001;16:107-11.
7. Belboul A, Löfgren C, Storm C, Jungbeck M. Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial. Eur J Cardiothorac Surg 2000;17:580-6.
8. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, etal. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83(Suppl. 5):S27-86.
9. Qiu F, Peng S, Kunselman A, Undar A. Evaluation of Capiox FX-05 oxygenator with an integrated arterial filter on trapping gaseous microemboli and pressure drop with open and closed purge line. Artif Organs 2010;34:1053-7.
10. Riley JB. Arterial line filters ranked for gaseous micro-emboli separation performance: an in vitro study. J Extra Corpor Technol 2008;40:21-6.
11. Skrabal CA, Choi YH, Kaminski A, etal. Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation. J Thorac Cardiovasc Surg 2006;132:291-6.
12. Biancari F, Rimpilainen R. Meta-analysis of randomized trials comparing the effectiveness of miniaturized versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart 2009;95:964-9.
13. Aal MA, El-Nahal N, Bakir BM, Fouda M. Mini-cardiopulmonary bypass impact on blood conservation strategy in coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2011;12:600-4.
14. Salis S, Mazzanti VV, Merli G, etal. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:814-22.
15. Onorati F, Santini F, Mariscalco G, etal. Leukocyte filtration ameliorates the inflammatory response in patients with mild to moderate lung dysfunction. Ann Thorac Surg 2011;92:111-21.
16. Myers GJ, Johnstone DR, Swyer WJ, etal. Evaluation of Mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol 2003;35:6-12.
17. Urban K, Redford D, Larson DF. Insulin binding to the cardiopulmonary bypass biomaterials. Perfusion 2007;22:207-10.
18. Hussaini BE, Treanor PR, Healey NA, etal. Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits. Perfusion 2009;24:317-23.
19. Deptula J, Valleley M, Glogowski K, Detwiler J, Hammel J, Duncan K. Clinical evaluation of the Terumo Capiox FX05 hollow fiber oxygenator with integrated arterial line filter. J Extra Corpor Technol 2009;41:220-5.
20. Ferraris V, Brown JR, Despotis GJ, etal. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011;91:944-82.
21. Eisses MJ, Geiduschek JM, Jonmarker C, Cohen GA, Chandler WL. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2007;21:28-34.
22. Izuha H, Hattori M, Igari T, Wakamatsu D, Watanabe T, Yokoyama H. Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material. J Artif Organs 2005;8:41-6.
23. Marcoux J, Sohn N, McNair E, etal. Outcomes comparison of 5 coated cardiopulmonary bypass circuits versus an uncoated control group of patients undergoing cardiac surgery. Perfusion 2009;24:307-15.
24. De Somer F, Francois K, van Oeveren W, etal. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 2000;18:602-6.
25. De Somer F, Van Belleghem Y, Caes F, etal. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002;17:39-44.
26. Pappalardo F, Della Valle P, Crescenzi G, etal. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2006;81:886-91.
27. Myers GJ, Voorhees C, Haynes R, Eke B. Post-arterial filter gaseous microemboli activity of five integral cardiotomy reservoirs during venting: an in vitro study. J Extra Corpor Technol 2009;41:20-7.
28. Barak M, Katz Y. Microbubbles: pathophysiology and clinical implications. Chest 2005;128:2918-32.
29. Dickinson TA, Riley JB, Crowley JC, Zabetakis PM. In vitro evaluation of the air separation ability of four cardiovascular manufacturer extracorporeal circuit designs. J Extra Corpor Technol 2006;38:206-13.
30. Weitkemper HH, Oppermann B, Spilker A, Knobl HJ, Korfer R. Gaseous microemboli and the influence of microporous membrane oxygenators. J Extra Corpor Technol 2005;37:256-64.
31. Morgan C, Zappitelli M, Gill P. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review. Crit Care 2009;13:165-76.
32. Hammon JW. Extracorporeal circulation: the response of humoral and cellular elements of blood to extracorporeal circulation. In: Cohn L, ed. Cardiac Surgery in the Adult. New York: McGraw-Hill, 2008;370-89.